{"id":"https://openalex.org/W3190145293","doi":"https://doi.org/10.1016/j.ygyno.2021.07.016","title":"Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial","display_name":"Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial","alternate_titles":[],"publication_year":2021,"publication_date":"2021-08-02","ids":{"openalex":"https://openalex.org/W3190145293","doi":"https://doi.org/10.1016/j.ygyno.2021.07.016","mag":"3190145293","pmid":"https://pubmed.ncbi.nlm.nih.gov/34353615","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9555119"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2021.07.016","doi":"https://doi.org/10.1016/j.ygyno.2021.07.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","pdf_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3190145293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103127347","display_name":"Nicoletta Colombo","orcid":"https://orcid.org/0000-0003-2225-715X","observed_orcids":["https://orcid.org/0000-0003-2225-715X"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nicoletta Colombo","raw_affiliation_strings":["University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: nicoletta.colombo@ieo.it","University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: nicoletta.colombo@ieo.it","institution_ids":["https://openalex.org/I6141010"]},{"raw_affiliation_string":"University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069337573","display_name":"Kathleen N. Moore","orcid":"https://orcid.org/0000-0002-5803-0718","observed_orcids":["https://orcid.org/0000-0002-5803-0718"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kathleen Moore","raw_affiliation_strings":["Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, United States","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026048739","display_name":"Giovanni Scambia","orcid":"https://orcid.org/0000-0002-9503-9041","observed_orcids":["https://orcid.org/0000-0002-9503-9041"]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giovanni Scambia","raw_affiliation_strings":["Fondazione Policlinico Universitario A Gemelli IRCCS, Universit\u00e0 Cattolica, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione Policlinico Universitario A Gemelli IRCCS, Universit\u00e0 Cattolica, Rome, Italy","institution_ids":["https://openalex.org/I2802557943","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067053417","display_name":"Ana Oaknin","orcid":"https://orcid.org/0000-0002-3592-7194","observed_orcids":["https://orcid.org/0000-0002-3592-7194"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ana Oaknin","raw_affiliation_strings":["Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021894535","display_name":"Michael Leonard Friedlander","orcid":"https://orcid.org/0000-0003-3090-795X","observed_orcids":["https://orcid.org/0000-0003-3090-795X"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Friedlander","raw_affiliation_strings":["University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4210108821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006039325","display_name":"Alla Sergeevna Lisyanskaya","orcid":"https://orcid.org/0000-0002-4495-9681","observed_orcids":["https://orcid.org/0000-0002-4495-9681"]},"institutions":[{"id":"https://openalex.org/I4210120731","display_name":"City Clinical Oncology Center","ror":"https://ror.org/02jwr3j75","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210120731"]}],"countries":["RU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alla Lisyanskaya","raw_affiliation_strings":["St Petersburg City Oncology Dispensary, St Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Petersburg City Oncology Dispensary, St Petersburg, Russia","institution_ids":["https://openalex.org/I4210120731"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091655083","display_name":"Anne Floquet","orcid":"https://orcid.org/0000-0002-1078-8554","observed_orcids":["https://orcid.org/0000-0002-1078-8554"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Floquet","raw_affiliation_strings":["Institut Bergoni\u00e9, Comprehensive Cancer Centre, Bordeaux, France; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France","Institut Bergoni\u00e9, Comprehensive Cancer Centre, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Bergoni\u00e9, Comprehensive Cancer Centre, Bordeaux, France; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"Institut Bergoni\u00e9, Comprehensive Cancer Centre, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025155327","display_name":"Alexandra F. Leary","orcid":"https://orcid.org/0000-0002-2043-2244","observed_orcids":["https://orcid.org/0000-0002-2043-2244"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexandra Leary","raw_affiliation_strings":["Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France; Institut Gustave-Roussy, Villejuif, France","Institut Gustave-Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France; Institut Gustave-Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Institut Gustave-Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048535376","display_name":"Gabe S. Sonke","orcid":"https://orcid.org/0000-0001-8088-9628","observed_orcids":["https://orcid.org/0000-0001-8088-9628"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabe S. Sonke","raw_affiliation_strings":["The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009351129","display_name":"Charlie Gourley","orcid":"https://orcid.org/0000-0002-2377-7221","observed_orcids":["https://orcid.org/0000-0002-2377-7221"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlie Gourley","raw_affiliation_strings":["Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065447416","display_name":"Susana N. Banerjee","orcid":"https://orcid.org/0000-0002-8840-7934","observed_orcids":["https://orcid.org/0000-0002-8840-7934"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susana Banerjee","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust, and Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust, and Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072712459","display_name":"Amit M. Oza","orcid":"https://orcid.org/0000-0002-9510-8641","observed_orcids":["https://orcid.org/0000-0002-9510-8641"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amit Oza","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007606531","display_name":"Antonio Gonz\u00e1lez-Mart\u00edn","orcid":"https://orcid.org/0000-0001-8376-9576","observed_orcids":["https://orcid.org/0000-0001-8376-9576"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Gonz\u00e1lez-Mart\u00edn","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra, Madrid, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054602117","display_name":"Carol A Aghajanian","orcid":"https://orcid.org/0000-0003-0851-3225","observed_orcids":["https://orcid.org/0000-0003-0851-3225"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carol Aghajanian","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027894385","display_name":"William Hampton Bradley","orcid":"https://orcid.org/0000-0002-6949-5262","observed_orcids":["https://orcid.org/0000-0002-6949-5262"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William H. Bradley","raw_affiliation_strings":["Froedtert and the Medical College of Wisconsin, Milwaukee, WI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Froedtert and the Medical College of Wisconsin, Milwaukee, WI, United States","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046657476","display_name":"Jae\u2010Weon Kim","orcid":"https://orcid.org/0000-0003-1835-9436","observed_orcids":["https://orcid.org/0000-0003-1835-9436"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jae-Weon Kim","raw_affiliation_strings":["Seoul National University, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University, Seoul, South Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001069897","display_name":"Cara Amanda Mathews","orcid":"https://orcid.org/0000-0001-8461-4568","observed_orcids":["https://orcid.org/0000-0001-8461-4568"]},"institutions":[{"id":"https://openalex.org/I4210133025","display_name":"Women & Infants Hospital of Rhode Island","ror":"https://ror.org/03z8sn326","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210133025"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cara Mathews","raw_affiliation_strings":["Women & Infants Hospital, Providence, RI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women & Infants Hospital, Providence, RI, United States","institution_ids":["https://openalex.org/I4210133025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060953135","display_name":"Joyce F. Liu","orcid":"https://orcid.org/0000-0003-3888-3972","observed_orcids":["https://orcid.org/0000-0003-3888-3972"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joyce Liu","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034781155","display_name":"Elizabeth Lowe","orcid":"https://orcid.org/0000-0003-3573-7208","observed_orcids":["https://orcid.org/0000-0003-3573-7208"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth S. Lowe","raw_affiliation_strings":["Astrazeneca, Gaithersburg, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, Gaithersburg, MD, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083667911","display_name":"Ralph Bloomfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ralph Bloomfield","raw_affiliation_strings":["AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033923828","display_name":"Paul DiSilvestro","orcid":"https://orcid.org/0000-0003-2711-6663","observed_orcids":["https://orcid.org/0000-0003-2711-6663"]},"institutions":[{"id":"https://openalex.org/I4210133025","display_name":"Women & Infants Hospital of Rhode Island","ror":"https://ror.org/03z8sn326","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210133025"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul DiSilvestro","raw_affiliation_strings":["Women & Infants Hospital, Providence, RI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women & Infants Hospital, Providence, RI, United States","institution_ids":["https://openalex.org/I4210133025"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":26,"corresponding_author_ids":["https://openalex.org/A5103127347"],"corresponding_institution_ids":["https://openalex.org/I6141010"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":2.7703,"has_fulltext":true,"cited_by_count":49,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93677923,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"163","issue":"1","first_page":"41","last_page":"49"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.9879999756813049},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7260000109672546},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8309999704360962},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7829999923706055},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.8679999709129333},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":1.0},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.7429999709129333},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.946245551109314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9012453556060791},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7588961124420166},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7377287149429321},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6900147199630737},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.634596586227417},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6095602512359619},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5878821015357971},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.45844268798828125},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.44398367404937744},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4249257743358612},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.41363051533699036},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.41051924228668213},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32917308807373047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2613018751144409},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2604585289955139},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D024682","descriptor_name":"BRCA2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1016/j.ygyno.2021.07.016","doi":"https://doi.org/10.1016/j.ygyno.2021.07.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","pdf_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},{"id":"pmid:34353615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34353615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic oncology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pure.ed.ac.uk:openaire/de765d8b-f4ed-4afe-b08b-4fd9f011730d","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/de765d8b-f4ed-4afe-b08b-4fd9f011730d","pdf_url":null,"source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Colombo, N, Moore, K, Scambia, G, Oaknin, A, Friedlander, M, Lisyanskaya, A, Floquet, A, Leary, A, Sonke, G S, Gourley, C, Banerjee, S, Oza, A, Gonz\u00e1lez-mart\u00edn, A, Aghajanian, C, Bradley, W H, Kim, J, Mathews, C, Liu, J, Lowe, E S, Bloomfield, R & Disilvestro, P 2021, 'Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial', Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2021.07.016","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:recercat.cat:11351/7785","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11351/7785","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientia","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9555119","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9555119/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Gynecol Oncol","raw_type":"Text"},{"id":"pmh:oai:boa.unimib.it:10281/324268","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10281/324268","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.ygyno.2021.07.016","doi":"https://doi.org/10.1016/j.ygyno.2021.07.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","pdf_url":"https://doi.org/10.1016/j.ygyno.2021.07.016","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3190145293.pdf","grobid_xml":"https://content.openalex.org/works/W3190145293.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1970948379","https://openalex.org/W2160466424","https://openalex.org/W2412266476","https://openalex.org/W2528228811","https://openalex.org/W2560045000","https://openalex.org/W2737389832","https://openalex.org/W2754327139","https://openalex.org/W2804717005","https://openalex.org/W2885844784","https://openalex.org/W2893157368","https://openalex.org/W2896628407","https://openalex.org/W2897430921","https://openalex.org/W2906986535","https://openalex.org/W2942893873","https://openalex.org/W2951045020","https://openalex.org/W2975141952","https://openalex.org/W2976139792","https://openalex.org/W3088796366","https://openalex.org/W3111515234"],"related_works":["https://openalex.org/W2947120195","https://openalex.org/W7133208703","https://openalex.org/W2886255359","https://openalex.org/W2899252745","https://openalex.org/W3141293352","https://openalex.org/W3195520437","https://openalex.org/W2947053671","https://openalex.org/W4220774697","https://openalex.org/W4392632737","https://openalex.org/W2952430909"],"abstract_inverted_index":{"OBJECTIVES:":[0],"In":[1],"the":[2,37,43,114,151,163,200,222],"phase":[3],"III":[4],"SOLO1":[5],"trial":[6],"(NCT01844986),":[7],"maintenance":[8],"olaparib":[9,59,164,175,193,205,212],"provided":[10],"a":[11,25,74,145,157,214,245],"substantial":[12],"progression-free":[13],"survival":[14],"benefit":[15],"in":[16,30,51,78,85,87,131,162,178,221,244],"patients":[17,55,89,183,190],"with":[18,73,171,181,226],"newly":[19,223],"diagnosed,":[20],"advanced":[21],"ovarian":[22],"cancer":[23],"and":[24,40,47,121,142,150,216,240],"BRCA":[26],"mutation":[27],"who":[28,90],"were":[29,56,83,169,198,237],"response":[31],"after":[32],"platinum-based":[33],"chemotherapy.":[34],"We":[35],"analyzed":[36,84],"timing,":[38],"duration":[39],"grade":[41],"of":[42,96,113,137,147,154,159,186,204,247],"most":[44,79,115,179],"common":[45,116],"hematologic":[46,117],"non-hematologic":[48,122],"adverse":[49,126,167,218],"events":[50,127,168,233],"SOLO1.":[52],"METHODS:":[53],"Eligible":[54],"randomized":[57,88],"to":[58,110,242],"tablets":[60],"300":[61,206],"mg":[62,207],"twice":[63,208],"daily":[64],"(N":[65,70],"=":[66,71,101,105],"260)":[67],"or":[68],"placebo":[69],"131),":[72],"2-year":[75],"treatment":[76,173],"cap":[77],"patients.":[80,133,248],"Safety":[81],"outcomes":[82],"detail":[86],"received":[91],"at":[92,194],"least":[93],"one":[94],"dose":[95,176,203],"study":[97],"drug":[98],"(olaparib,":[99],"n":[100,104],"260;":[102],"placebo,":[103],"130).":[106],"RESULTS:":[107],"Median":[108],"time":[109],"first":[111,135,152],"onset":[112],"(anemia,":[118],"neutropenia,":[119,139],"thrombocytopenia)":[120],"(nausea,":[123],"fatigue/asthenia,":[124],"vomiting)":[125],"was":[128],"<3":[129],"months":[130,149,161],"olaparib-treated":[132],"The":[134],"event":[136,153,219],"anemia,":[138],"thrombocytopenia,":[140],"nausea":[141],"vomiting":[143],"lasted":[144,156],"median":[146,158],"<2":[148],"fatigue/asthenia":[155],"3.48":[160],"group.":[165],"These":[166],"manageable":[170,217,239],"supportive":[172],"and/or":[174],"modification":[177],"patients,":[180],"few":[182],"requiring":[184],"discontinuation":[185,243],"olaparib.":[187],"Of":[188],"162":[189],"still":[191],"receiving":[192,199],"month":[195],"24,":[196],"64.2%":[197],"recommended":[201],"starting":[202],"daily.":[209],"CONCLUSIONS:":[210],"Maintenance":[211],"had":[213],"predictable":[215],"profile":[220],"diagnosed":[224],"setting":[225],"no":[227],"new":[228],"safety":[229],"signals":[230],"identified.":[231],"Adverse":[232],"usually":[234],"occurred":[235],"early,":[236],"largely":[238],"led":[241],"minority":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3190145293","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2021-08-16T00:00:00"}
